Next Biosciences is thrilled to announce a strategic partnership with Adcock Ingram, leader in eye care in South Africa. This exciting collaboration will optimise efficiency and positively impact the distribution of our biological ophthalmology products: AmnioMatrix and OptiSerum.
Adcock Ingram will take charge of marketing and sales, leveraging their industry expertise and extensive market presence, while Next Biosciences will remain focused on manufacturing these unique biological products in our ISO13485 accredited laboratory.
We look forward to this exciting new chapter as we embark on this journey with Adcock Ingram. Together, we're redefining the landscape of eye care and paving the way for a brighter, clearer future.
Placental membranes have been used since the mid 1900’s for wound healing and as a foundation material for the regrowth of soft tissue.
AmnioMatrix is produced from the amnion membrane of the placental membranes.
AmnioMatrix is used as an ophthalmic therapy product which helps reduce pain and stimulate healing of eye wounds. It acts a biological scaffold for new cells to grow on and contains vital growth factors and cytokines that are integral in the repair of eye wounds.
Patients who suffer from the following:
Your ophthalmologist will advise products required for surgery. They will order this directly from us should it be a surgical requirement.
Please contact your ophthalmologist for more information.
